The YouTuber identifies Cellavision as a quality small-cap stock that has become attractive after a significant price drop. He notes its market leadership in digital microscopes for blood analysis, strong balance sheet management (debt reduction), and potential for future dividend increases. While acknowledging its volatility due to its small market and sensitivity to large orders, he sees significant long-term potential at the current valuation.
“Cellavision habe ich momentan auch noch nicht aber ein Auge drauf geworfen.”